loader2
Partner With Us NRI

Anuh Pharma Ltd share Price Today

Company details

229.00
236.90
85.00
265.00
6M Return 80.45%
1Y Return 175.52%
Mkt Cap.(Cr) 1,172.97
Volume 64,372
Div Yield 0.86%
OI
-
OI Chg %
-
Volume 64,372

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Anuh Pharma Ltd shares SWOT Analysis

Strengths (11)

  • Company with high TTM EPS Growth
  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Highest Recovery from 52 Week Low

Threats (2)

  • Promoter decreasing their shareholding
  • Increasing Trend in Non-Core Income

Resistance and support

R1 237.2
R2 241.0
R3 245.1
Pivot

233.08

S1 229.3
S2 225.2
S3 221.4
EMA SMA
237.9
219.2
195.3
166.9
238.6
217.7
188.1
156.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
KETAN LALIT SHAH Bulk Sell 2020-09-29 196.62 145700 BSE
KETAN LALIT SHAH Bulk Purchase 2015-05-07 675.03 76900 BSE
LALIT POPATLAL SHAH Bulk Purchase 2015-05-07 676.28 69404 BSE
Name Category Shares
BHARTI BIPIN SHAH PROMOTER 19.43%
LALITKUMAR POPATLAL SHAH PROMOTER 8.81%
BIPIN NEMCHAND SHAH (HUF) PROMOTER 8.47%
BHARAT NEMCHAND SHAH PROMOTER 3.73%
MRUDULA JAYANTILAL SHAH PROMOTER 2.33%
DINA SATISH SHAH PROMOTER 2.22%
BIPIN NEMCHAND SHAH PROMOTER 6.21%
PRAFULLA LALIT SHAH PROMOTER 5.66%
GAURAV SATISH SHAH PROMOTER 3.19%
VIVEK BIPIN SHAH PROMOTER 2.33%
RITESH BIPIN SHAH PROMOTER 2.31%
SAMIR JAYANTILAL SHAH PROMOTER 1.72%
KINJAL SIDDHARTH JHAVERI PROMOTER 0.81%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Anuh Pharma Ltd Stocks COMPARISON

Financials( in Cr) Anuh Pharma Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 234.05 1,540.00 1,396.80 6,083.85 3,779.70
% Change 0.26 -3.99 -1.84 -1.20 1.09
Mcap Cr 1,172.97 369,497.59 112,770.65 101,484.09 100,339.32
Revenue TTM Cr 527.49 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 36.18 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 21.53 39.38 28.51 19.41 72.54
1 Year Return 175.52 52.69 54.88 27.82 29.90
ROCE 20.82 16.79 14.76 25.99 19.30
ROE 15.90 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 241.23 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,771.53 7,735.64
LAST 3M 82,392.14 52,275.07
LAST 6M 132,482.07 84,624.18
LAST 12M 206,189.80 211,987.34

Anuh Pharma Ltd Information

Stock PE (TTM)
21.53
Promoter Holding
69.94%
Book Value
51.2329
ROCE
20.82%
ROE
15.9%
Description
  • Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of "Bulk drugs and chemicals Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group. Anuh Pharma Ltd was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs. The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries. During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg. During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production. In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption. In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption. In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption. The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011. In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine. In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It received CEP for Ambroxol Hydrochloride from EDQM in 2022.

Registered Address

3-A Shivsagar Estate, North Wing Dr A B Road Worli, Mumbai, Maharashtra, 400018

Tel : 91-22-6622 7575
Email : anuh:sk1932.com
Website : http://www.anuhpharma.com
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 506260
NSE Code :
Book Closure Date (Month) : Aug
BSE Group : X
ISIN : INE489G01022

FAQ’s on Anuh Pharma Ltd Shares

You can buy Anuh Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Anuh Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 12, 2024 04:01 PM the closing price of Anuh Pharma Ltd was ₹ 234.05.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 12, 2024 04:01 PM, the market cap of Anuh Pharma Ltd stood at ₹ 1,172.97.

The latest PE ratio of Anuh Pharma Ltd as of Apr 12, 2024 04:01 PM is 21.53

The latest PB ratio of Anuh Pharma Ltd as of Apr 12, 2024 04:01 PM is 0.22

The 52-week high of Anuh Pharma Ltd share price is ₹ 265.00 while the 52-week low is ₹ 85.00

Download Our

Download App
market app